Sabby Management’s Armata Pharmaceuticals ARMP Stock Holding History

Sabby Management’s Portfolio ARMP Stock Details ARMP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-58,293	Closed	-$168K	–	85
2018 Q4	$168K	Buy	+58,293	New	+$284K	0.04%	75
2018 Q2	–	Sell	-59,426	Closed	-$907K	–	148
2018 Q1	$907K	Buy	+59,426	New	+$1.05M	0.11%	69
2017 Q4	–	Sell	-10,661	Closed	-$136K	–	161
2017 Q3	$136K	Sell	10,661 -41,583	-80%	-$532K	0.01%	135
2017 Q2	$570K	Buy	52,244 +50,066	+2,299%	+$1.21M	0.04%	133
2017 Q1	$507K	Sell	2,178 -8,671	-80%	-$589K	0.03%	178
2016 Q4	$668K	Buy	10,849 +7,125	+191%	+$886K	0.04%	173
2016 Q3	$782K	Sell	3,724 -660	-15%	-$152K	0.03%	202
2016 Q2	$951K	Buy	+4,384	New	+$1.51M	0.05%	165

Other funds holding ARMP

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PAM

Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

SXL

Summit X LLC Chesterfield, Missouri $536M AUM 15.36% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

FWM

Frontier Wealth Management Kansas City, Missouri $1.38B AUM 6.3% 1-Year Est. Return

Sabby Management's ARMP Position: Q1 2019 in Review

Sabby Management sold out of Armata Pharmaceuticals (ARMP) in Q1 2019, closing a stake of 58,293 shares — an estimated $168K sold.

Sabby Management first reported a position in ARMP in Q2 2016 and held it in 8 quarters. The position peaked at $951K in Q2 2016. 25 funds tracked by Wall St. Rank hold ARMP as of Q1 2019.

Sabby Management reported no remaining Armata Pharmaceuticals position as of Q1 2019 after selling out during the quarter.
Sabby Management sold 58,293 Armata Pharmaceuticals shares in Q1 2019, an estimated $168K.
Sabby Management first reported a position in Armata Pharmaceuticals in Q2 2016 and held it in 8 quarters.
Sabby Management's Armata Pharmaceuticals position peaked at $951K in Q2 2016.
25 funds tracked by Wall St. Rank held Armata Pharmaceuticals as of Q1 2019.

Based on Sabby Management's 13F filing for Q1 2019, filed 15 May 2019.